Completed PHASE4 INTERVENTIONAL 2-arm NCT03385356

Impact of Vitamin D Supplementation in Patients With Multiple Sclerosis

Sponsor: Medical Faculty Maribor

Conditions Multiple Sclerosis, Relapsing-Remitting Vitamin D Deficiency

Interventions Vitamin D

Updated 7 times since 2018 Last updated: Mar 18, 2019 Started: Dec 19, 2017 Primary completion: Apr 30, 2018 Completion: Apr 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Multiple Sclerosis, Relapsing-Remitting and Vitamin D Deficiency and is currently completed. Medical Faculty Maribor leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Apr 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Mar 2019 — Apr 2019 [monthly]

Recruiting PHASE4

▶ Show 2 earlier versions

Jun 2018 — Mar 2019 [monthly]

Recruiting PHASE4
Jan 2018 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical Faculty Maribor
University Medical Centre Maribor

Data source: University Medical Centre Maribor

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maribor, Slovenia